ニュース
The company formerly known a Sosei Heptares unveiled new weight loss programs. Elsewhere, BridgeBio and Madrigal unveiled ...
One vaccine expert called the move, which cancels some $500 million in messenger RNA research contracts, a “giant step ...
The company hopes an important CVS deal and broader legal action against the makers of knockoff Wegovy can solidify its slipping position in the lucrative market for weight loss drugs.
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する